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Lesion removalAnnexin-A5 (AnxA5) is the smallestmember of the annexins, a group of soluble proteins that bind tomembranes
containing negatively-charged phospholipids, principally phosphatidylserine, in a Ca2+-dependent manner.
AnxA5 presents unique properties of binding and self-assembling onmembrane surfaces, forminghighly ordered
two-dimensional (2D) arrays. We showed previously that AnxA5 plays a central role in the machinery of cell
membrane repair of murine perivascular cells, promoting the resealing of membrane damages via the formation
of 2D protein arrays at membrane disrupted sites and preventing the extension of membrane ruptures. As the
placenta is one of the richest source of AnxA5 in humans, we investigatedwhether AnxA5was involved inmem-
brane repair in this organ. We addressed this question at the level of human trophoblasts, either mononucleated
cytotrophoblasts or multinucleated syncytiotrophoblasts, in choriocarcinoma cells and primary trophoblasts.
Using established procedure of laser irradiation and ﬂuorescence microscopy, we observed that both human
cytotrophoblasts and syncytiotrophoblasts repair efﬁciently a μm2-size disruption. Compared to wild-type
cells, AnxA5-deﬁcient trophoblasts exhibit severe defect of membrane repair. Through speciﬁcally binding to
the disrupted site as early as a few seconds after membrane wounding, AnxA5 promotes membrane resealing
of injured human trophoblasts. In addition, we observed that a large membrane area containing the disrupted
site was released in the extracellular milieu. We propose mechanisms ensuring membrane resealing and subse-
quent lesion removal in human trophoblasts. This article is part of a Special Issue entitled: 13th European
Symposium on Calcium.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Plasma membrane disruption is a general phenomenon induced by
mechanical stress in physiological conditions, which leads to the entry
into cells of extracellular Ca2+ at mM concentration. Increase of intra-
cellular Ca2+ concentration activates the repair protein machinery in
eukaryotic cells ensuring a rapid resealing of large plasma membrane
ruptures and preventing cell death [1–3]. Several models of membrane
repair have been proposed, their occurrence probably depending on the
size and the type of rupture [2,4]. The classical model of membrane re-
pair is based on the formation of a lipid patch built by the fusion of intra-
cellular vesicles, followed by the recruitment of this patch at the
wounded site, which reseals the plasma membrane [5–8]. Recently itts;D-PBS,Dulbelcco'sphosphate
asts
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t Hilaire, 33600 Pessac, France.
ter).has been proposed that membrane repair relies primarily on exocytosis
of lysosomal sphingomyelinase, which hydrolyses phosphorylcholine
head group of sphingomyelin and induces the formation of ceramide-
driven membrane invaginations, thus triggering lesion removal by an
endocytic pathway [4,9]. Other groups have proposed that cell mem-
brane repair occurs by removingmembrane lesion through bleb forma-
tion [10] or shedding [11] using notably the ESCRT complex [12].
According to the classicalmodel ofmembrane repair, mM-Ca2+ sen-
sitive proteins, like dysferlin [13–15], MG-53 [16], AHNAK [17], calpains
[18,19] and annexins [20–23], allow cytoplasmic vesicles to fuse and
form a lipid patch, which is recruited to the damaged site of the plasma
membrane. The membrane repair machinery starts to be identiﬁed, yet
remains largely unknown. As defect in membrane repair is responsible
for the development of muscular dystrophies such as limb–girdle mus-
cular dystrophy type-2B andMiyoshimyopathy [13,14] and limb–girdle
muscular dystrophy type-1C [24], major attention on membrane repair
focused on skeletalmuscle cells. Little is yet known onmembrane repair
in other tissues.
The human placental trophoblast is the primary barrier separating
maternal blood from fetal blood. This epithelium-like tissue covering
2034 R. Carmeille et al. / Biochimica et Biophysica Acta 1853 (2015) 2033–2044the placenta is a two-layered structure, the outer layer forming syncytia
[25], named syncytiotrophoblasts (ST), which expands by fusion of un-
derlying progenitor mononucleated cytotrophoblasts (CT) throughout
pregnancy (Scheme 1). ST are the site of numerous placental functions
including gas, ion and nutrient exchange and hormone synthesis re-
quired for fetal growth and development [26,27]. The trophoblastic
layers protrude as ﬁnger-shaped villi in the intervillous space where
the maternal blood circulates from the beginning of the second trimes-
ter. The apical membrane of ST is formed of very abundant but fragile
microvilli bathing in maternal circulation. Surface expansion of the ST
increases from 0.3-m2 at 12 weeks of pregnancy to about 13-m2 at
term [25]. The number of CT fusing with preformed ST along pregnancy
exceeds the required number for cell maintenance and growth [28]. The
excess of material is shed from the syncytial surface into the maternal
blood as ST-derived particles, named knots, sprouts or syncytial
exosomes [29,30]. A very large amount of syncytial particles is shed
per day, estimated at 4.7 × 104 and 8.5 × 105 particles for a 12-weeks
and a 9-months placenta, respectively [25,31]. The molecular mecha-
nisms leading to ST-derived particles shedding and the required pro-
cesses of membrane repair at the site where a syncytial knot/sprout
breaks away, are poorly understood. The revelation of the unexpected
presence in ST of dysferlin, a major component of the muscle cell mem-
brane repair machinery, hitherto supposed being speciﬁc to skeletal
muscle, highlighted the existence of a machinery enabling an efﬁcient
plasma membrane repair in trophoblasts [32].
Disturbances of ST formation or functions are observed in patholog-
ical conditions. Preeclampsia, eclampsia and other pregnancy diseases
are associated with exacerbated trophoblast deportation into maternal
blood [33–37]. The deportation of trophoblast knots induces inﬂamma-
tory response of maternal endothelial cells, directly involved in the
physiopathology of preeclampsia [29]. As placental dysferlin expression
drops by 38% in severe preeclampsia [38], a defect in membrane repair
in preeclamptic ST may be hypothesized.
The annexins (Anx), a protein family presenting 12 members in
humans, share the property of binding to negatively-charged lipid
membranes, primarily those containing phosphatidylserine (PS) in a
Ca2+-dependent manner [39]. Several of their properties argue for
their contribution inmembrane repair processes such as their participa-
tion in numerous endo- and exo-cytic events by interaction withScheme 1. Simpliﬁed scheme displaying trophoblasts localization in the placenta. A.F.: amnioti
U.C.: umbilical cord; U.W.: uterine wall.ﬁlamentous actin [40,41] and their ability to aggregate membranes
[42,43]. During the last decade,many annexins have been shown to par-
ticipate in membrane repair processes. AnxA1 and AnxA2 trigger intra-
cellular vesicles fusion during the lipid patch formation and promote its
attachment to the plasma membrane, by interacting with dysferlin at
sarcolemma in normal muscle [20,21]. The absence of interactions be-
tweenAnxA1-A2 and dysferlin is associated to a defect inmembrane re-
pair in dysferlinopathic mouse [20]. Recently, it has been shown that
membrane repair of zebraﬁsh skeletal musclemay be based on building
of a highly ordered scaffold involving dysferlin, AnxA6, AnxA2 and
AnxA1, in a chronological order [23]. Our group demonstrated that
AnxA5 plays a critical role in membrane repair of murine perivascular
cells by forming a two-dimensional (2D) array at the level of the torn
membrane edges. This 2D array prevents wound expansion, which is
due to the tension exerted by cytoskeleton, and promotes membrane
resealing [22].
As the placenta is one of the richest source of AnxA5 in humans, we
investigated whether AnxA5 was involved in membrane repair in this
organ. First we assessed the ability of human trophoblasts to repair
their plasmamembrane and subsequently examined the role of endog-
enous and extracellular AnxA5 in this process. We addressed this ques-
tion at the level of thehuman trophoblastic BeWocell line andof human
primary trophoblasts, either mononucleated CT or multinucleated ST.
Using established procedures of laser irradiation and ﬂuorescence mi-
croscopy, we compared the response of wild-type trophoblastic cells,
which express constitutively AnxA5, and cells rendered deﬁcient in
AnxA5 by RNA interference. We found that endogenous AnxA5 pro-
motes membrane resealing in both CT and ST, by interacting with plas-
ma membrane at the injured site. The results achieved through this
study led us to proposemechanisms for membrane resealing and lesion
removal after membrane injury in human trophoblasts.2. Materials and methods
2.1. Cell culture
Cell culture media and reagents were from Invitrogen (Thermo
Fisher Scientiﬁc, Waltham, MA, USA) except when otherwise stated.c ﬂuid; F.B.V.: fetal blood vessels; I.V.S.: intervillous space; M.B.V.: maternal blood vessels;
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atmosphere, 5% CO2).
2.1.1. Placental tissue collection and culture of primary trophoblasts
Term placentas were obtained after Caesarean section from healthy
mothers with uncomplicated pregnancies delivered at 37–41 weeks of
gestation. These biological samples were obtained following informed
patient written consent and approval from local ethics committee
(CCPPRB, Paris Cochin, N°18-05, Paris, France). Term villous CT were
isolated from chorionic villi by differential sequential trypsin digestion
and further puriﬁed on percoll gradient as previously described [44].
Cells were maintained in culture over 72 h in complete DMEM to form
ST.
2.1.2. Culture of BeWo cells
The choriocarcinomaBeWo cell linewas cultured inHam's F12Kme-
dium supplemented with 20% fetal bovine serum, 5-mM L-glutamine,
100-units/mL penicillin and 100-μg/mL streptomycin and passaged
twice a week to keep them in logarithmic growth. Differentiation and
fusion of BeWo cells were induced by incubating the cells with 100-
μM 8-Br-cAMP (Sigma) for 48-h in growth condition.
2.2. Western blotting
2.106 cells were trypsinized, pelleted and re-suspended in 300 μL of
Dulbelcco's phosphate buffer saline (D-PBS) depleted in Ca2+ and sup-
plementedwith 1-mMEGTA. Protein extractswere obtained by sonicat-
ing the ice-cold cell solution with a Branson digital soniﬁer (amplitude
20%, duration 2-min, interval 5-s and pulse 5-s). Two successive centri-
fugations at 13,000-g for 1-min allowed to remove cell debris. 10-μg
protein extracts were separated on a 10% SDS-PAGE. Semi-dry electro-
phoretic transfer (Bio-Rad) onto PVDF membrane was performed for
1-h at 100-V. The cellular content of AnxA5 and GAPDH (loading con-
trol) was detected with a mouse anti-AnxA5 monoclonal antibody
(Sigma) and a rabbit anti-GAPDH polyclonal antibody (Santa Cruz), re-
spectively. Both antibodies were diluted 1:1000 in saturation solution
composed by Tris buffer saline (10-mMTris, 150-mMNaCl, pH8.0) sup-
plemented with 0.1% Tween20 and 5% non-fat dry milk. Revelation was
performed using secondary antibodies coupled to horse-radish peroxi-
dase (Amersham) diluted 1:2000 in saturation solution and Opti-
4CN™ colorimetric kit (Bio-Rad).
2.3. Membrane rupture and repair assay
BeWo cells and primary trophoblasts were cultured in complete
growth medium without red phenol on 8-well Ibidi-treat μslideTM
(Biovalley). Cells were incubated 5-min before acquisition with 5-
μg/mL FM1−43FX (referred to hereafter as FM1−43 (Invitrogen)) in
D-PBS and maintained over ice. To induce membrane damage, cells
were irradiated at room temperature (20–21 °C), at 820-nm with a
Chameleon-Vision™ mode-locked Titanium:Saphire laser (Coherent
Inc, CA, USA) of a two-photon confocal scanning microscope (TCS SP2
AOBS, Leica) equipped with an HCX PL APO CS 63.0 × 1.40 oil-
objective lens. Irradiation consisted of 3 successive scans (1.6 s per
scan) of a 1-μm × 1-μm area with a power of 110-mW. 512 × 512 im-
ages were acquired at 1.6-s intervals with pinhole set to 1 Airy unit.
For each condition, at least 100 cells from three independent experi-
ments were analyzed. Two independent experiments are – conducted
on different days,− performed on cells with different passage numbers
and performed with freshly prepared FM1−43 and D-PBS solutions.
Membrane rupture and repair processes were monitored by mea-
suring the variations in ﬂuorescence intensity of FM1−43. FM1−43
was excited by the 488-nm laser line (intensity set at 40% of maximal
power) and ﬂuorescence emission was measured between 520-nm
and 650-nm. For quantitative analysis, the ﬂuorescence intensity was
integrated over thewhole cell surface and corrected for theﬂuorescencevalue recorded before irradiation, using ImageJ program. In order to
characterize the magnitude and the rate of FM1−43 uptake, the ﬂuo-
rescence intensity changes were ﬁtted according to the following
“mono-exponential rise to maximum” equation [45]: Fluorescence In-
tensity = (1− exp(−B * t)) * A, where A corresponds to the maximal
intracellular ﬂuorescence intensity and B is equal to Ln2/τ½. This
model implying the existence of a plateau, only repairing cells were
therefore analyzed. Curve ﬁtting was performed using Sigmaplot soft-
ware (Systat Software inc., San Jose, USA).
2.4. Localization of endogenous AnxA5 in intact and damaged BeWo cells
For analysis in damaged BeWo cells, 2.105 cells were cultured in a
35-mm glass bottom dish equipped with a square-patterned coverslip
(MatTek, Ashland, USA). Cellmembrane rupturewasperformed accord-
ing to the protocol described above, but in the absence of FM1−43 to
avoid ﬂuorescence cross-talk. Cells were ﬁxed in 4% paraformaldehyde
at room temperature after laser irradiation was completed. Fixation
was terminated by adding 50-mMNH4Cl. All subsequent steps (perme-
abilization, incubation with antibody and washes) were performed
using 0.1% Triton X-100 and 1% BSA in D-PBS solution. Mouse anti-
AnxA5 monoclonal antibody (Sigma) and secondary Alexa488-
coupled anti-mouse goat antibody (Invitrogen) were successively incu-
batedwith cells for 1-h at 37 °C. Finally, cells werewashed in D-PBS and
a nuclear counterstaining was performed with DAPI (Sigma). For each
condition, about 10 cells from three independent experiments were
analyzed.
For analysis of intact cells, 2.104 cells/cm2 were cultured in 8-well
Ibidi-treat μslideTM. Cells were immunostained employing the same
protocol as described above for damaged cells from the step of parafor-
maldehyde ﬁxation.
2.5. Localization of extracellular AnxA5 in damaged BeWo cells
Cells were incubated over ice in the presence of 3-μg.mL−1 Cy5-
AnxA5 in D-PBS containing 1 mM Ca2+ for 5-min before irradiation.
Cell membrane rupture was performed according to the protocol de-
scribed above, but in the absence of FM1−43 to avoid ﬂuorescence
cross-talk. Cy5-AnxA5 was excited by the 633-nm laser line (intensity
set at 60% maximal power) and its emission recorded between 650-
and 750-nm.
2.6. Immunodetection of AnxA5 at the surface of undamaged trophoblastic
cells
2.104/cm2 primary trophoblasts or BeWo cells were cultured in 8-
well Ibidi-treat μslideTM. Live cells were incubated in the presence of
anti-AnxA5 antibody coupled to Alexa488 for 45 min à 4 °C in D-PBS
supplemented with 1-mM Ca2+. After D-PBS washes, cells were ﬁxed
by 4% paraformaldehyde. As control, some cells were immunostained
in the same conditions but after 4%-paraformaldehyde ﬁxation and Tri-
ton X-100 permeabilization.
2.7. AnxA5-targetting siRNA transfection in BeWo CT
Reverse and forward siRNA transfection protocols were successively
applied on 2.104 BeWo cells/cm2. AnxA5-targetting siRNAs were from
Invitrogen and consisted in a mix of two sequences: siRNA_A5_1 5′
GGGCUGAUGCAGAAACUCUUCGGAA3′and siRNA_A5_2 5′GAGGAAAC
CAUUGACCGCGAGACUU3′. Transfection protocol (for 2.104 cells)
consisted in incubating 2-pmol of AnxA5-targetting siRNAs and 0.6-μL
RNAimaxTM lipofectant solution (Invitrogen) in 50 μL Optimem, for
30-min at room temperature. The mixture was added drop-by-drop
on trypsinized cell suspension (Reverse method) or adherent cells
(Forward method) maintained in growth medium depleted in antibi-
otics. After 4-h incubation at 37 °C, transfection medium was replaced
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transfection.
2.8. AnxA5-targetting shRNA lentiviral particle transduction in BeWo ST
The following shRNA sequences, cloned into the pLKO.1 puro-vector
(MISSION® shRNA plasmids, Sigma), were used:
AnxA5-targetting shRNA: 5′-CCGGCGCGAGACTTCTGGCAATTTACTC
GAGTAAATTGCCAGAAGTCTCGCGTTTTT-3′; Control non-target
shRNA: 5′-CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTA
ACCTTAGG-3′.
Lentiviral-based particles containing shRNAswere produced by Bor-
deaux University Lentiviral Vectorology Platform (US005, Bordeaux,
France) by transient transfection of 293 T cells. Bewo cells were plated
at 2.104 cells per well in 8-well Ibidi-treat μslideTM and incubated for
24-h in completemedium. Transductionwas carried out by adding con-
centrated lentiviral particles to the cells at multiplicity of infection of 30
in complete medium depleted in antibiotics for 24-h. The medium was
then replacedwith fresh completemediumsupplementedwith 100-μM
8-BrcAMP for 24-h. Cells were subsequently incubated with complete
medium containing1-μg/ml puromycin (Sigma) in order to select trans-
duced cells. 24-h after antibiotic treatment, membrane repair assays
were performed as described above.
3. Results
3.1. Membrane repair assay in human trophoblasts
In order to examinemembrane repair ability of human trophoblasts
at the level of CT and ST, BeWo cells were cultured either in the absence
or in the presence of 100-μM8-Br-cAMP for 48 h, respectively.Whereas
BeWo cells remain as mononucleated cells (hereafter referred as BeWo
CT) in free-cAMP growth condition, they differentiate and fuse in the
presence of cAMP, forming large multinucleated cells (hereafter
referred as BeWo ST). Typical images of BeWo CT and BeWo ST are
presented in Figure S1.
We applied a well-established protocol of cell membrane disruption
based on near infra-red laser irradiation [14,22]. By focusing the laser on
plasmamembrane for a few seconds, a μm2-sizemembrane rupturewas
created in a controlled and highly reproducible way. To assess mem-
brane disruption and repair, cells are irradiated in the presence of
FM1–43, awater-soluble dyewhichbecomesﬂuorescent upon inserting
into lipidmembranes, yet is unable to crossmembranes. Therefore, cells
with damagedplasmamembrane exhibit an increase of ﬂuorescence in-
tensity due to the passive entrance of FM1–43 molecules into the cyto-
sol and their incorporation into intracellularmembranes. The process of
membrane repair is monitored by time-lapse imaging of cytoplasmic
FM1–43 ﬂuorescence intensity after irradiation. Membrane resealing
leads to a stop in the entry of FM1–43 molecules into the cytosol and
therefore to a stop in the increase of the intracellular ﬂuorescence
intensity.
Membrane repair assaywasﬁrst performed on BeWoCT in the pres-
ence of 1-mM Ca2+ (Fig. 1A). Irradiation conditions were adjusted
(110-mW) to cause mild membrane injury to cells, as indicated by the
absence of a large disruption at the irradiated site (Fig. 1A-frame 2,
arrow). The cytoplasmic ﬂuorescence intensity increased locally as
early as a few seconds after irradiation (Fig. 1A-frames 2–3), indicating
the presence of amembrane rupture. 120-s after plasmamembrane dis-
ruption (Fig. 1A-frame 4), we observed that entry of FM1–43 remained
limited to an area close to the disruption site. Analysis of the kinetics of
intracellular ﬂuorescence intensity variations showed that ﬂuorescence
increased for about 80-s and then reached a plateau (Fig. 1D, blue ﬁlled
circles). The plateau indicated that entrance of FM1–43 molecules
stopped and therefore that plasma membrane had resealed. Ca2+ isknown to be a crucial component of membrane repair processes by ac-
tivatingmost, if not all, of the steps of membrane resealing. As a control
experiment, BeWo CT were irradiated in the absence of Ca2+ (Fig. 1B).
In this condition, damaged BeWo CT exhibited a large entry of FM1–
43 within the cell, characterized by a continuous and large increase of
intracellular ﬂuorescence intensity (Fig. 1D, blue ﬁlled triangles). This
result indicated the absence of membrane resealing and validated the
assay. When BeWo ST were submitted to the same irradiation condi-
tions in the presence of 1-mM Ca2+, these cells exhibited an increase
of intracellular ﬂuorescence limited to an area of a few μm2 around
the disruption site (Fig. 1C). The FM1–43 ﬂuorescence intensity was ob-
served to increase for a few seconds and then to reach a plateau (Fig. 1D,
blue empty circles), indicating that cell membrane resealed rapidly. In
the absence of Ca2+, BeWo ST are unable to reseal their plasma mem-
brane (Fig. S2), indicating that membrane resealing is also strictly
Ca2+-dependent in these cells. In order to characterize the membrane
resealing process, the magnitude (A) and the rate (τ1/2) of FM1–43 up-
take were determined (Fig. 1E). A and τ1/2 are respectively about eight
and ﬁfteen times lower for BeWo ST compared to BeWo CT. These two
parameters indicate an enhanced ability of BeWo ST to reseal damaged
plasma membrane.
The membrane repair assay was applied to human primary tropho-
blastic cells isolated from term placenta of healthymothers. Primary CT
differentiate and fuse spontaneously over three days of culture. Mem-
brane repair ability of primary CT and ST were therefore investigated
24 h and 72 h after seeding, respectively. Primary trophoblasts behaved
like BeWo cells, both of them are able to reseal their plasmamembrane,
with a more efﬁcient repair for ST (Fig. 1D, black empty circles, and
Fig. S3) compared to CT (Fig. 1D, black ﬁlled circles, and Fig. S3).We ob-
served that the A and τ1/2 parameters are higher for primary cells com-
pared to BeWo cells (Fig. 1E), indicating a faster process of resealing in
BeWo cells. Many cell debris were observed in the medium during the
assay (Fig. S3, arrowheads), suggesting a high fragility of primary cells.
For this reason, we performed most of the further experiments with
BeWo cells.
3.2. AnxA5 expression in human trophoblasts
By Western-blot analysis, we examined the relative expression of
AnxA5 in BeWo cells and in human primary trophoblasts at the cyto-
and syncytio-trophoblastic levels. AnxA5 is expressed at a similar level
in BeWo CT and BeWo ST (Fig. 2A, left-hand lanes). The amount of en-
dogenous AnxA5 was estimated at 3.5-ng/μg protein extract in both
cell states. Primary CT and ST also expressed AnxA5 in a similar level
with a concentration about three times higher than BeWo cells
(Fig. 2A, middle lanes). We conclude therefore that AnxA5 is expressed
at similar level in human CT and ST.
3.3. Subcellular distribution of endogenous AnxA5 in human trophoblasts
As we previously proposed that the formation of AnxA5 2D array at
plasma membrane damaged sites was responsible for a strengthening
of the membrane preventing the expansion of membrane tears [22],
we investigated the subcellular localization of endogenous AnxA5 in in-
tact and membrane-damaged BeWo cells. In intact cells, we observed
that AnxA5 localizes in the nucleus and in the cytoplasm of BeWo CT
(Fig. 2B, upper line) and BeWo ST (Fig. 2B, bottom line), in agreement
with previous studies in BeWo cells [46] and other cell lines [47]. Prima-
ry CT and ST displayed the same subcellular localization of AnxA5
(Fig. S4). The homogenous distribution of AnxA5 within the cytoplasm
supposes that it localizes in the cytosol. Some BeWo CT exhibited a
stronger staining along the plasma membrane, exclusively localized at
the cell–cell contacts (Fig. 2B, top left, arrowheads). This result corre-
lates with a pleated shape of plasmamembrane, as observed in DICmi-
croscopy (Fig. 2B, top right, arrowheads). This stronger staining most
Fig. 1. Responses of human trophoblasts to membrane injury by laser irradiation. (A) Sequence of representative images showing the response of a BeWo CT to 110-mW infrared laser
irradiation in the presence of 1 mM Ca2+. (B) Sequence of representative images showing the response of a BeWo CT to 110-mW infared laser irradiation in the presence of 1 mM
EGTA. Before irradiation, cells were washed 3 times in D-PBS devoid of Ca2+ and subsequently incubated in D-PBS supplemented with 1 mM EGTA for 5-min. (C) Sequence of represen-
tative images showing the response of a BeWo ST to 110-mW infrared laser irradiation in the presence of 1 mM Ca2+. In all Figures, the area of membrane irradiation is marked with a
white arrow before irradiation and a red arrow after irradiation. Image frames 1 and 2were recorded 1.6 s before and 1.6 s after irradiation, respectively; Image frames 3–4were recorded
64 s and 120 s after irradiation, respectively, as indicated. Scale bars= 20 μm. (D) Kinetic data represent the FM1−43 ﬂuorescence intensity integrated over whole cell sections, averaged
for 30 cells (+/−SD) and100 cells (+/−SD) for primary and BeWocells, respectively. In the presence of 1-mMCa2+ (+Ca), theﬂuorescence intensities reach a plateauwithin the time of
experiment for BeWo CT (blue ﬁlled circles), BeWo ST (blue empty circles), primary CT (black ﬁlled circles) and primary ST (black empty circles) indicating cell membrane reseals. In the
absence of Ca2+ (−Ca), the ﬂuorescence intensity measured in BeWo CT (blue ﬁlled triangles) increases continuously and is signiﬁcantly larger than for the four other conditions. This
result indicates the absence of membrane resealing. (E) Fluorescence intensity changes (mean values from (D)) were ﬁtted according to the “mono-exponential rise to maximum” equa-
tion. A and τ1/2 refer respectively to themaximal ﬂuorescence intensity and the time required to observe the half-maximum ﬂuorescence intensity. N.A. and a.u. stand for “not applicable”
and “arbitrary unit”, respectively. A and τ1/2 are systematically lower for ST compared to CT, indicating an enhanced ability of ST to reseal damaged plasma membrane.
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two cells rather than a membrane localization.
We then assessed the subcellular localization of AnxA5 in laser-
injured BeWo cells. Most previous studies dealing with the dynamics
of intracellular proteins during cell membrane rupture and repair,
have been based on the use of ﬂuorescent fusion proteins [12,16,23].
Nevertheless, it remains elusive how an endogenous protein coupled
to a 30-kDaﬂuorescent proteinmay fully conserve its trafﬁc and protein
interaction properties within the cell. Here we opted for studying resi-
dent endogenousAnxA5using tools developed for correlativemicrosco-
py. BeWo cells were cultured in glass bottom dishes equipped with a
square-patterned coverslip displaying an alphanumerical code in eachsquare, thus enabling accurate tracking of irradiated cells. After irradia-
tion, cellswereﬁxed, permeabilized and immunostained for AnxA5. The
localization of AnxA5 was studied for various time intervals (from 5 to
15-min) between irradiation and ﬁxation. 5-min after laser injury, en-
dogenous AnxA5 was found to accumulate speciﬁcally at the disruption
site of BeWo CT and ST (Fig. 2C, upper frames). Strikingly, the presence
of AnxA5 at the rupture site was retained in about 50% of cells ﬁxed 15-
min after plasmamembrane disruption (Fig. 2C, bottom frames).When
similar experiments were performed in buffer devoid of Ca2+, we did
not detect the presence of AnxA5 at the disrupted site, indicating its re-
cruitment is strictly Ca2+-dependent (data not shown). It has been re-
ported that intracellular Ca2+ concentration drops rapidly to its initial
Fig. 2. Expression and subcellular distribution of endogenous AnxA5 in intact and damaged human trophoblasts. (A) The cellular content of AnxA5 in BeWo CT, BeWo ST, primary CT and
primary ST was quantiﬁed throughWestern blot analysis, by comparison with 50-ng puriﬁed recombinant AnxA5 (Pure A5). 10-μg protein extract were separated on a 10% SDS-PAGE.
AnxA5 and GAPDH (loading control) were respectively detected with a mouse anti-AnxA5 monoclonal antibody and a rabbit anti-GAPDHmonoclonal antibody. The amount of endoge-
nousAnxA5was estimated at 3.5 ng/μg protein extract and 10ng/μg protein extract in BeWo cells and primary trophoblasts, respectively. (B) Subcellular localization of endogenousAnxA5
in intact BeWo CT (upper line) and intact BeWo ST (bottom line) was analyzed by immunocytoﬂuorescence. Cells were observed by ﬂuorescence microscopy for AnxA5 (green) and by
differential interference contrast microscopy (DIC). Scale bar= 50 μm. (C) Subcellular localization of endogenous AnxA5 in damaged BeWo CT (left-hand column) and damaged BeWo ST
(right-hand column) was analyzed by immunocytoﬂuorescence. Cells were irradiated with a 110-mW infrared laser in D-PBS containing 1-mM Ca2+ and ﬁxed in 4% paraformaldehyde
solution 5-min (upper panels) and 15-min (bottom panels) after laser irradiationwas completed. Cells were immunostained for AnxA5 (green) and counterstainedwith DAPI (blue). The
area of membrane irradiation is marked with a red arrow. Scale bar = 10 μm.
Fig. 3. Subcellular localization of endogenous AnxA5 in un-permeabilized laser-injured
BeWo cells. Subcellular localization of endogenous AnxA5 in damaged BeWo CT was ana-
lyzed by immunocytoﬂuorescence without the permeabilization step. Cells were irradiat-
ed with a 110-mW infrared laser in D-PBS containing 1-mM Ca2+ and ﬁxed in 4%
paraformaldehyde solution 5-min (left-hand column) and 15-min (right-hand column)
after laser irradiation was completed. Cells were immunostained for AnxA5 (green) and
counterstained with DAPI (blue). The area of membrane irradiation is marked with a
red arrow. Scale bar = 20 μm.
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12]. Given that AnxA5 is known to be released from the membrane
when Ca2+ concentration falls below 0.2-mM [48], its presence at dam-
aged membrane site several minutes after resealing suggests that it is
trapped in poorly accessible environments. The size of the ﬂuorescent
area where AnxA5 accumulated remained constant with time, estimat-
ed at 4 (±2)-μm2 and 6 (±3)-μm2 for BeWo CT and BeWo ST, respec-
tively. As we did not observe interaction between AnxA5 and plasma
membrane anywhere else in the irradiated cells, we conclude that resi-
dent endogenous AnxA5 binds exclusively to the disruption site of
laser-injured plasma membrane.
When laser-injured BeWo CT and BeWo ST (data not shown) were
immunostained for AnxA5 without the permeabilization step, we ob-
served that a signiﬁcant part of AnxA5 was accessible to antibodies at
the level of disruption site (Fig. 3). The possibility that antibodies en-
tered the cell due to the action of paraformaldehyde was ruled out by
the absence of staining at other places than the disrupted site. We ob-
served that the size of ﬂuorescent areas formed by endogenous
AnxA5 at disrupted sites in permeabilized (Fig. 2C) and non-
permeabilized cells (Fig. 3, around 4-μm2)were similar. This result indi-
cates that, among the AnxA5 molecules accumulating at the disrupted
site, a large part of them either interacts with the outer leaﬂet of the
plasma membrane as soon as the disruption occurs or interacts with
the inner leaﬂet when rupture is occurring and is excluded from the cy-
tosol when membrane reseals.
3.4. Binding of extracellular AnxA5 to human intact and damaged
trophoblasts
Some studies have reported the existence of AnxA5 in the extracel-
lular milieu [49,50]. In the human placenta, it has been suggested that
extracellular AnxA5may cover the ST layer [51], preventing blood coag-
ulation [52]. We investigated therefore whether AnxA5molecules were
constitutively associatedwith the outer leaﬂet of the plasmamembrane
in non-injured BeWo and primary CT and ST. Live cells were incubated
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in the presence of 1-mM Ca2+. Incubation was performed at 4 °C in
order to prevent, or slow down, endocytosis and to reduce unspeciﬁc
entry of antibody into the cell. In these conditions, most BeWo CT
showed no ﬂuorescence at all (Fig. 4A). The only few BeWo CT that
were labeled displayed an altered morphology, characteristic of an apo-
ptotic or necrotic state (Fig. 4A, arrow). Control experiment conﬁrmed
the capacity of anti-AnxA5 antibody to interact with AnxA5 in these
conditions of incubation (Fig. 4B). Similar results were found with pri-
mary CT (Fig. 4C) and ST (Fig. 4D), which allow us to conclude that
AnxA5 is not constitutively present ex vivo at the surface of non-
injured CT and ST.
In order to analyze the behavior of extracellular AnxA5 during cell
membrane rupture, we irradiated BeWo cells in the presence of
exogenously-added Cy5-AnxA5. Before membrane rupture, no AnxA5
staining was observed, indicating the absence of free PS exposed at
the cell surface (Fig. 5, frame 1). As soon as 1.6-s after laser-injury of
BeWo CT, extracellular AnxA5 was observed localizing exclusively at
the disrupted site (Fig. 5, frame 2). Extracellular AnxA5 continued to ac-
cumulate at the disruption site for at least 1-min after laser irradiation
(Fig. 5, frame 3–4). Similar results were obtained with BeWo ST
(Fig. S5).
Since intact ST and CT do not expose PS at the cell surface, we con-
clude that binding of exogenous AnxA5 to membrane damaged areas
in laser-irradiated cells reﬂects the transient and local exposure of PS
molecules present in the inner leaﬂet of the plasma membrane.
We conclude also that both endogenous and exogenous AnxA5
molecules are able to be recruited at disruption site within 2‐ s after
membrane injury.
3.5. Membrane repair ability of human AnxA5-deﬁcient trophoblasts
In order to investigate the possible consequences of the absence of
endogenous AnxA5 for membrane repair in trophoblastic cells, BeWo
CT were transfected with AnxA5-targetting siRNAs. 48-h after two suc-
cessive siRNA transfections, the content of endogenous AnxA5 in BeWo
CT dropped by 90 ± 6% (n = 7), reaching a residual concentration of
0.3 (±0.08) ng/μg total protein extract (Fig. S6A). Immunocytochemis-
try analysis showed that transfected BeWo CT population was
homogenously affected by AnxA5 knock-down (Fig. S6B).
When siRNA-transfected BeWo CT were submitted to cell mem-
brane disruption, two types of response were observed. Most of
transfected BeWo CT (67%) exhibited a large and deep entry of FM1–
43 (Fig. 6A, upper panel), characterized by a strong and continuous in-
crease of intracellular ﬂuorescence intensity during the time ofFig. 4. Assessment of the presence of AnxA5 at the surface of human trophoblasts. Living BeWo
antibody coupled to Alexa-488 for 45-min at 4 °C in the presence of Ca2+ (A, C andD). As contro
conditions (B).White arrows point out two cells and/or cell debrisﬂoating in themedium. No A
40 μm.experiment (Fig. 6B, empty circles). This result indicates a defect of
membrane resealing. The remaining 33% of cells behaved like un-
transfected BeWo CT with an entry of FM1–43 limited to an area close
to the plasmamembrane (Fig. 6A, bottompanel), and a plateau of intra-
cellular ﬂuorescence intensity after about 100-s (Fig. 6B, ﬁlled circles);
the repair kinetic parameters of these cells (Fig. 6C) were similar to
those measured for un-transfected cells (Fig. 1E). The fact that about
one third of cells within transfected cell population showed an efﬁcient
repair is likely to reﬂect the fact the transfection yield is not 100% and
that some cells conserve a residual concentration of AnxA5 sufﬁcient
for achieving membrane resealing. We conclude therefore that the ab-
sence of endogenous AnxA5 leads to a defect of membrane repair in
BeWo CT.
Several strategies were developed in order to establish AnxA5-
deﬁcient BeWo ST. We ﬁrst tried to transfect BeWo CT with AnxA5-
targetting siRNAs and subsequently to induce cell fusion by the addition
of 8-BrcAMP. These cells were unable to fuse (data not shown). This ob-
servation indicates that AnxA5may play a role in fusion of trophoblastic
cells as it was proposed for myoblasts [53]. We also tried to transfect
BeWo ST directly. However, the short lifetime of BeWo ST, together
with their relative fragility, prevented us from obtaining a signiﬁcant
amount of viable cells. In addition BeWo ST surviving transfection
steps exhibited a low decrease (inferior to 5%) of endogenous AnxA5
amount (data not shown). In order to overcome this problem,we decid-
ed to use shRNA lentiviral transduction strategy, which is particularly
adapted for non-dividing cells. When BeWo ST were transduced with
AnxA5-targetting shRNA lentiviral particles, we observed that most
cells (75%) were unable to reseal laser-injured plasma membrane
(Fig. 7A, upper panels and Fig. 7B, blue empty circles).Membrane repair
was observed for the remaining 25% of cells (Fig. 7A, bottom panels and
Fig. 7B, blue ﬁlled circles), which nevertheless exhibited a slower
resealing characterized by kinetic parameters with A = 24.9 a.u. and
τ1/2 = 11.5 s (Fig. 7C, A5-shRNA, 25%) instead of 9.8 a.u. and 10.2 s for
BeWo ST transduced with lentiviral particles containing a scrambled
shRNA sequence (Fig. 7B, black ﬁlled circles and Fig. 7C, ctrl).
We conclude that the absence of endogenous AnxA5 in human tro-
phoblasts, at both CT and ST levels, leads to a defect inmembrane repair.
3.6. Which mechanism ensures lesion removal in human trophoblasts?
During the course of this study we made the following observation
that provides novel insight on the process of lesion removal. We ob-
served with about half of BeWo and primary ST that the lipid material
accumulated at the disrupted sitewas released from the cell aftermem-
brane resealing (Fig. 8). Two modus operandi were observed: either aCT (A and B) and primary CT (C) and ST (D) were incubated with monoclonal anti-AnxA5
l, a batch of BeWo CTwas ﬁxed, permeabilized and immunostained for AnxA5 in the same
nxA5was detectable at the surface of human trophoblasts ex vivo (A, C and D). Scale bar=
Fig. 5. Binding of extracellular AnxA5 to the disrupted site of injuredmembrane. Simultaneous recording in ﬂuorescence microscopy (upper panels) and bright ﬁeld microscopy (bottom
panels) of a BeWo CT submitted to 110-mW laser-induced membrane rupture in the presence of 3-μg/ml Cy5-AnxA5 (white) diluted in D-PBS containing 1-mM Ca2+. The area of mem-
brane irradiation ismarkedwith awhite arrowbefore irradiation and a red arrow after irradiation. Image frames 1 and 2were recorded 1.6 s before and 1.6 s after irradiation, respectively;
Image frames 3 and 4were recorded 64 s after irradiation. Image frame 4 is a high-magniﬁed image from frame 3. Extracellular AnxA5 binds exclusively at the disrupted site of the injured
membrane. Scale bars = 20 μm.
2040 R. Carmeille et al. / Biochimica et Biophysica Acta 1853 (2015) 2033–2044large fragment (about 100-μm2) containing the wounding site moved
away from the cell (Fig. 8A) or the area containing the disrupted site
crumbled through membrane debris (about 5-μm2) release (Fig. 8BFig. 6. Responses of AnxA5-deﬁcient BeWo CT to cell membrane injury. (A) Sequences of rep
siRNA to 110-mW infared-laser irradiation in the presence of 1-mM Ca2+. Image series show t
for un-transfected cells with an entry of FM1–43 limited to a small area near the disruption site
rescence intensity indicating the absence ofmembrane resealing. The area ofmembrane irradiat
frames 1 and 2 were recorded 1.6 s before and 1.6 s after irradiation, respectively; Image fram
(B) Kinetic data represent the FM1–43 ﬂuorescence intensity integrated over whole cell sectio
ﬂuorescence intensity reaches a plateau within the time of experiment indicating cell membran
in AnxA5-targetting siRNA transfected BeWo CT increases continuously indicating the absence o
ing to the “mono-exponential rise tomaximum” equation.Mean values frommembrane repair a
unit”, respectively.and C). We observed that release of lipid material from the disrupted
area began from 1-min or later after membrane disruption (Fig. 8, see
also Fig. 1C), indicating that this process may correspond, not toresentative images showing the response of BeWo CT transfected with AnxA5-targetting
wo types of response: a minor fraction (about 33%, bottom panels) responds as observed
. A major fraction (about 67%, upper panels) presents a large increase of intracellular ﬂuo-
ion ismarkedwith awhite arrowbefore irradiation and a red arrow after irradiation. Image
es 3–4 were recorded 64 s and 120 s after irradiation, respectively. Scale bars = 20 μm.
ns, averaged for about 100 cells (+/−SD). For the minor fraction (33%, ﬁlled circles), the
e reseals. For themajor fraction (67%, empty circles), the ﬂuorescence intensity measured
f membrane resealing. Fluorescence intensity changes (data from (B))were ﬁtted accord-
ssayswere used for this curve ﬁtting. N.A. and a.u. stand for “not applicable” and “arbitrary
Fig. 7.Responses of AnxA5-deﬁcient BeWo ST to cellmembrane injury. (A) Sequences of representative images showing the response of BeWo ST transducedwith lentiviral particles con-
tainingAnxA5-targetting shRNA to 110-mWinfared-laser irradiation in thepresence of 1-mMCa2+. Image series show two types of response: aminor fraction (about 25%, bottompanels)
exhibits an increase of intracellular ﬂuorescence, which stops within 1-min, indicating cell membrane reseals. A major fraction (about 75%, upper panels) presents a large increase of in-
tracellular ﬂuorescence intensity indicating the absence of membrane resealing. The area of membrane irradiation is marked with a white arrow before irradiation and a red arrow after
irradiation. Image frames 1 and 2 were recorded 1.6 s before and 1.6 s after irradiation, respectively; Image frames 3–4 were recorded 64 s and 120 s after irradiation, respectively. Scale
bars= 20 μm. (B) Kinetic data represent the FM1–43 ﬂuorescence intensity integrated over whole cell sections, averaged for about 30 cells (+/−SD). For the minor fraction of BeWo ST
transduced with AnxA5-shRNA (A5-shRNA) lentiviral particles (25%, blue ﬁlled circles), the ﬂuorescence intensity reaches a plateau within the time of experiment indicating cell mem-
brane reseals. For the major fraction (75%, blue empty circles), the ﬂuorescence intensity increases continuously indicating the absence of membrane resealing. Kinetic data representing
the response of BeWo ST transducedwith lentiviral particles containing a scrambled shRNA are displayed (ctrl, blackﬁlled circles). (C) Fluorescence intensity changes (data from (B))were
ﬁtted according to the “mono-exponential rise to maximum” equation. The parameters were calculated for kinetic data of BeWo ST transduced with AnxA5-shRNA (A5-shRNA, 25%) and
scrambled shRNA (scr-shRNA, ctrl) lentiviral particles, which exhibitedmembrane resealing.Mean values frommembrane repair assayswere used for this curve ﬁtting. N.A. and a.u. stand
for “not applicable” and “arbitrary unit”, respectively.
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BeWo ST and all BeWo CT exhibited no beginning of wounded mem-
brane release within the 2-min range of the membrane repair assay.
Further investigations are required to determine what happens for
these cells over a longer period.
4. Discussion
4.1. Human trophoblasts present an efﬁcient repair machinery
The present study shows that ST reseal cell membrane disruption of
μm2-size within 30-s. This fast membrane resealing highlights the criti-
cal role of membrane repair processes for ST. Indeed, these syncytial
cells, which form the outer layer of the trophoblastic tissue and pro-
trude asﬁnger-shaped villi inmaternal blood, require protection and re-
pair mechanisms in order to counteract the mechanical constraints
induced by the shearing forces exerted bymaternal circulation. Further-
more, ST are submitted to the continuous supply of cellular material
provided by the fusion of underlying CT. Aging cytoplasmic content
and nuclei are clustered and shed into thematernal circulation through
ST-derived particles in 3–4 weeks [28,54]. It has been estimated that
around 1 × 108 ST-derived particles are shed over the entire gestational
period [25,29,31]. The molecular mechanism ensuring the formation of
these particles and the required process of membrane repair after shed-
ding, are poorly understood. A particular aspect to consider is that the
various types of damages that may affect the ST plasma membranewill result in the exposure of PS-containing membranes to maternal
blood. In view of the pro-coagulant properties of PS-exposing mem-
branes, efﬁcient mechanisms of membrane repair must operate in the
placenta to prevent onset of blood coagulation, which could be life-
threatening for the fetus.
The present study shows also that CT, although they are not in con-
tact with maternal blood, reseal cell membrane disruption of μm2-size
within 100-s. The development and regeneration of ST require the fu-
sion of underlying CT. By providing ST with a large part of their cellular
content, CTmay offer themain components of the repairmachinery. It is
noteworthy that dysferlin, a major membrane repair protein in skeletal
muscle, may be lacking in CT [32]. This ﬁnding raises the essential issue
of the role played by dysferlin in membrane repair in these cells. The
possibility that the absence of dysferlin may be compensated by the
presence of myoferlin [55] should be investigated.
4.2. AnxA5 promotes membrane resealing in human trophoblasts
Annexins have been shown to participate in membrane repair pro-
cesses in numerous studies [20–23]. In this study, we focused our atten-
tion on AnxA5, because it is expressed at high level in the placenta, and
because we reported previously its role in membrane resealing in mu-
rine perivascular cells [22]. CT and ST, rendered deﬁcient in AnxA5 by
RNA interference, suffer from a severe defect inmembrane resealing, in-
dicating that AnxA5 is a crucial component of the repair machinery in
human trophoblasts. In a few seconds after membrane injury,
Fig. 8. Lesion removal of BeWo ST after cell membrane injury. (A) and (B) display two sequences of representative images showing two types of lesion removal from the disruption site of
laser-injured BeWo ST. Cell membrane injury was performed through 110-mW infrared laser irradiation in the presence of 1 mM Ca2+. In all ﬁgures, the area of membrane irradiation is
markedwith awhite arrow before irradiation and a red arrow after irradiation. Image frames 1 and 2were recorded 1.6 s before and 1.6 s after irradiation, respectively; Image frames 3–4
were recorded 64 s and 120 s after irradiation, respectively. In (A) the white arrowhead point out the removal of a large membrane fragment containing the disrupted site. In (B) the red
square surrounds the area displayed in (C). Scale bar= 20 μm. (C) Two different time lapses showing the shedding of two successivemembrane-derived debris (white arrowheads) from
the disrupted site of the laser-injured BeWo ST displayed in (B). Scale bar = 10 μm.
2042 R. Carmeille et al. / Biochimica et Biophysica Acta 1853 (2015) 2033–2044endogenous AnxA5 is speciﬁcally recruited, in a Ca2+-dependent man-
ner, to the disruption site, where it is retained several minutes after
membrane resealing. This result is consistent with the model we have
proposed previously [22]. AnxA5, triggered by the local increase in
Ca2+ entering the cell at mM-concentration, binds to PS molecules ex-
posed at the edges of torn membranes, where it may self-assemble
into 2D arrays. The formation of AnxA5 2D array may strengthen the
membrane and prevent the expansion of the tear, by counteracting
membrane tension due to the cortical cytoskeleton. The intracellular
Ca2+ concentration has been found to drop rapidly after membrane
resealing [11,12], at a level that is incompatible with AnxA5 binding to
PS. The presence of AnxA5 several minutes after membrane resealing,
suggests therefore it is trapped in a lipid environment where Ca2+ re-
mains at mM concentration.
4.3. Which mechanisms ensure membrane resealing and lesion removal?
Inwounded human trophoblasts, a large amount of lipidmaterial ac-
cumulating at the disrupted site is detected as early as a few seconds
aftermembrane disruption. Even if the nature of accumulating lipidma-
terial is not determined in our experiments, the variation of intracellular
FM1–43ﬂuorescence intensity (see for instance Fig. 1C) suggests the cy-
toplasmic origin of this lipid material. Two main models of cell mem-
brane repair are currently proposed. The classical model relies on
Ca2+-triggered fusion of intracellular vesicles, which may form a lipid
patch enabling membrane resealing via an exocytosis-like process [5,
7,8]. Besides, a new model has been recently proposed: Ca2+ entry
through membrane disruption triggers exocytosis of lysosomes, which
secrete acid sphingomyelinase in the extracellularmilieu. Subsequently,
hydrolysis of phosphorylcholine head group of sphingomyelin activates
endocytosis, which mediates lesion removal [56,57]. It is unlikely that
the fast membrane resealing observed in ST may be accomplishedthrough ceramide-driven invagination induced by exocytosis of lyso-
somal enzymes. For instance, it was observed that secretion of signiﬁ-
cant amount of acid sphingomyelinase can take up to several minutes
[57], inconsistent with a fast membrane resealing, in the second range.
In addition, through speciﬁc binding to the disrupted site as early as a
few seconds after membrane disruption, AnxA5 is a good reporter of
the lesion fate. In most trophoblasts, AnxA5 is retained at the irradiated
membrane region several minutes after membrane resealing. All to-
gether, these results prompt to propose that the formation of a lipid
patch is likely responsible for membrane resealing in human
trophoblasts.
Concerning the lesion removal in injured human trophoblasts, we
frequently observed the shedding either of a large piece (about 100-
μm2) including the disrupted site or of burst of μm2-size membrane de-
bris from the lesion. This lesion removal begins at the earliest 1-min
after membrane wounding. If released particles were already detected
from SLO-perforated HEK293 cells [58], we report here, to our knowl-
edge, the ﬁrst direct evidence of the release of the plasma membrane
wound.
5. Concluding remarks
Here we show that AnxA5 plays a central role in trophoblast mem-
brane repair by promoting membrane resealing. We propose that the
resealing process is primarily based on the formation of a lipid patch
and that the lesion removal is managed through the release into the ex-
tracellular milieu of membrane material containing the wounded site.
Whatever the membrane repair mechanism, we propose that AnxA5
achieves a universal and ubiquitous function, strengthening wounded
plasma membrane through an early binding to the disrupted site after
membrane injury. This binding prevents the extension of the tear by
counteracting membrane tension due to the cortical cytoskeleton.
2043R. Carmeille et al. / Biochimica et Biophysica Acta 1853 (2015) 2033–2044Several annexins have been shown to participate in plasma membrane
repair [20–23,59], suggesting the annexin family forms an emergency
team that orchestrates the cell membrane repair machinery, by
protecting cells against the direct and collateral effects of plasma mem-
brane rupture. Implication of other annexins, apart from AnxA5, in tro-
phoblast membrane repair remains to be investigated. Furthermore,
similarities and differences in mechanisms ensuring membrane repair
in trophoblasts and other cell types remain elusive.Most studies dealing
withmembrane repair have focused until now on skeletal muscle, since
it has been demonstrated that defect in membrane repair leads to mus-
cular dystrophy [13,14,24]. Although a relationship between defective
membrane repair and placental pathologies has not yet been clearly
established, it is noteworthy that severe pre-eclampsia is associated
with an expression of the trophoblastic dysferlin, a major component
of the muscle repair machinery, dropped by 38% [38].
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